Cholecystokinin and its antagonists in pain management
Saved in:
Main Authors: | |
---|---|
Published: |
Haworth Medical Press,
|
Publisher Address: | New York |
Publication Dates: | c2006. |
Literature type: | Book |
Language: | English |
Series: |
Haworth series in clinical pain and symptom palliation |
Subjects: | |
Carrier Form: | 145 p.: ill. ; 22 cm. |
ISBN: |
0789028921 (hard : alk. paper) 9780789028921 (hard : alk. paper) 078902893X (soft : alk. paper) 9780789028938 (soft : alk. paper) |
Index Number: | R977 |
CLC: |
R977.4 R977.6 R975 |
Call Number: | R975/M126 |
Contents: |
Includes bibliographical references (p. 115-142) and index. Introduction -- Opioids in pain management -- Cholecystokinin -- Cholecystokinin as a gut peptide -- Cholecystokinin as a central nervous system peptide -- Central effect of cholecystokinin -- Factors that increase central cholecystokinin representation -- Cholecystokinin as an antiopioid peptide -- Cholecystokinin receptor antagonists -- Do cholecystokinin antagonists influence opioid-derived antinociception? -- Do CCK antagonists reduce tolerance to the antinociceptive effects of opioids? -- Is the combination of opioids and CCK antagonists safe? -- Human studies of the combination of CCK |